However, the role of TGF-β in EMT is functionally complex, and studies have reported that the disruption of TGF-β signaling can affect EMT by reducing E-cadherin expression and upregulated N-cadherin and Snail expression in mouse models of prostate cancer [30]. Here, TGFB1 is linked to prostate carcinoma.